Explanation of the data of State Agency of Medicines of Latvia

Explanation of the data of State Agency of Medicines of Latvia

25/02/2013

JSC Grindeks confirms that the turnover of the company’s (not the Group’s) self-manufactured products in 2012 was 55.5 million lats, based on the State Agency of Medicines of Latvia data.

This data does not reflect performance of the Group in the previous year. The Group non-audited results of 2012 will be published on 28 February 2013. The turnover of the Group in 2011 was 69.6 million lats. As previously reported, indicator of the turnover in 2012 will reach the increase above 10%, compared to the previous year.

Further information: 

Laila Kļaviņa
Head of the Communications Department, JSC Grindeks
Phones: (+371) 67083370, (+371) 29256012
Fax: (+371) 67083505
E-mail: [email protected]

Related posts

ImgNews4

Grindeks celebrates 75-year anniversary

Today on December 21, JSC Grindeks, the leading pharmaceutical manufacturer in the Baltic States celebrates its 75-year anniversary. Over these 75 years, Grindeks has become...
21/12/2021
magnifiercrossmenu